Back to Results


Title The FIND-CKD Study: a trial for patients with non-diabetic chronic kidney disease.
Therapeutic Area Chronic Kidney Disease, Proteinuria, Kidney Diseases
Principal Investigator Daniel Weiner, MD
Min Age 18 Years
Gender Any
Contact Amy Wyle
More Information


The purpose of this clinical trial is to see if the drug Finerenone is safe and effective in patients with in participants with non-diabetic chronic kidney disease. Additionally, while finerenone has been approved for other patient populations, this study will collect additional safety information about finerenone to determine how it affects the body.

Study Details

Inclusion Criteria

  • History of organ transplantation
  • Established diagnosis of Type 1 or 2 Diabetes mellitus

    If you aren't sure you qualify, please call us and we will help determine your eligibility

Exclusion Criteria

Study Requirements

If you qualify, you will receive either the study drug finerenone or placebo for 32-49 months. We will then follow up with you for 1 month. Visit frequency is approximately every 1-4 months.